Read More Pharma Industry News GenSight Biologics completes LUMEVOQ tech transfer to Catalent to enable global clinical expansion GenSight Biologics advances gene therapy LUMEVOQ® through strategic manufacturing transfer to Catalent, bolstering regulatory readiness and clinical scale-up. byPallavi MadhirajuJune 26, 2025